CervoMed Inc. Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments
CervoMed Inc. (CRVO) reported Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-20.
Discontinued › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 · last filed 2015-04-03
- CervoMed Inc. change in unrealized gain (loss) on fair value hedging instruments for the quarter ending 2014-03-31 was $0.00.
- CervoMed Inc. change in unrealized gain (loss) on fair value hedging instruments for the quarter ending 2013-12-31 was $0.00.
- CervoMed Inc. change in unrealized gain (loss) on fair value hedging instruments for the quarter ending 2013-09-30 was $0.00.
- CervoMed Inc. change in unrealized gain (loss) on fair value hedging instruments for the quarter ending 2013-06-30 was $9.22M.
- CervoMed Inc. change in unrealized gain (loss) on fair value hedging instruments for fiscal 2013 was $8.98M.
- CervoMed Inc. change in unrealized gain (loss) on fair value hedging instruments for fiscal 2012 was -$6.91M.
| Period end | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 3 month | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 6 month | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 9 month | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 9 month as first filed | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 12 month | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-20 | $0.00 derived: sum of 2 quarters · filed 2015-04-03 | $0.00 derived: sum of 3 quarters · filed 2015-04-03 | $9.22M derived: sum of 4 quarters · filed 2015-04-03 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | $0.00 derived: sum of 2 quarters · filed 2015-04-03 | $9.22M derived: sum of 3 quarters · filed 2015-04-03 | $8.98M 10-K · filed 2015-04-03 | -$8.98M 10-K/A · filed 2014-04-23 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 | $9.22M derived: sum of 2 quarters · filed 2014-08-14 | $8.98M 10-Q · filed 2014-11-12 | -$8.98M 10-Q · filed 2013-11-19 | -$11.77M derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-06-30 | $9.22M 10-Q · filed 2014-08-14 | $8.98M 10-Q · filed 2014-08-14 | -$11.77M derived: sum of 3 quarters · filed 2014-08-14 | |||
| 2013-03-31 | -$236.85K 10-Q · filed 2014-05-20 | -$20.99M derived: sum of 2 quarters · filed 2014-05-20 | ||||
| 2012-12-31 | -$20.75M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | -$6.91M 10-K/A · filed 2014-04-23 | ||||
| 2012-09-30 | $13.85M 10-Q · filed 2013-11-19 | |||||
| 2012-06-30 | -$2.02M 10-Q · filed 2013-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |